In this case series, we discuss an alternative approach in selected patients with severe cardiogenic shock to use a VA-ECMO as bridge-to-recovery, enhanced by introducing very early heart failure medication, including ACE inhibitors and beta blockers using enoximone and ECMO. This evidence concerns the gene ACE and heart failure.